Click on image to view larger version.

Figure 4 Kaplan-Meier analyses show that in patients with acute heart failure, at presentation the combination of a galectin-3 in excess of 9.42 ng/ml combined with amino-terminal pro-brain natriuretic peptide (NT-proBNP) above the optimal cut point (5,562 pg/ml) was associated with higher rates of death (A) or mortality/recurrent heart failure (B) than either of the 2 markers alone.